WeMed Medical Welcomes South Asian Distributor For Evaluation Of Coronary Interventional Surgical Robot

From August 31 to September 1, WeMed Medical hosted representatives from a South Asian medical device distributor at its headquarter for a comprehensive two-day field evaluation and business negotiation. The visit focused on WeMed's industry background, research and development (R&D) and manufacturing capabilities, and its flagship product, the Endovascular Robotic System.

During the two-day engagement, WeMed Medical presented a detailed overview of its growth history, operational scale, and production standards, accompanied by a hands-on simulation demonstration of the interventional robot's core functionality and precision capabilities. The delegation expressed high regard for WeMed Medical's technical background, innovative product architecture, and post-sales service responsiveness.

Following the evaluations, both parties reached a preliminary consensus regarding regional distribution and market entry strategies for South Asia. This visit underscores international market confidence in WeMed Medical's technology and marks a key step in expanding the footprint of its Endovascular Robotic System globally.